Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Butler

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322Karen O'Dwyer, Meredith Hackel, Sarah Hightower, et al.
BMC Health Services Research|November 17, 2017
Low uptake of Aboriginal interpreters in healthcare: exploration of current use in Australia's Northern TerritoryAnna P Ralph, Anne Lowell, Jean Murphy, et al.
BMJ Open|May 15, 2022
Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage studyMatthew J L Hare, Yuejen Zhao, Steven Guthridge, et al.
Lancet (London, England)|February 11, 2024
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trialsFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniaeSharon Min, Karen Ingraham, Jianzhong Huang, et al.
Future Microbiology|February 24, 2025
Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infectionFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Trials|February 20, 2025
Opportunities and challenges to delivering a trial for depressive symptoms in primary care during the COVID-19 pandemic: insights from the Alpha-Stim-D randomised controlled trialShireen Patel, Priya Patel, Clement Boutry, et al.
The Lancet. Psychiatry|February 1, 2023
Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trialRichard Morriss, Shireen Patel, Clement Boutry, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322Karen O'Dwyer, Meredith Hackel, Sarah Hightower, et al.
BMC Health Services Research|November 17, 2017
Low uptake of Aboriginal interpreters in healthcare: exploration of current use in Australia's Northern TerritoryAnna P Ralph, Anne Lowell, Jean Murphy, et al.
BMJ Open|May 15, 2022
Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage studyMatthew J L Hare, Yuejen Zhao, Steven Guthridge, et al.
Lancet (London, England)|February 11, 2024
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trialsFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniaeSharon Min, Karen Ingraham, Jianzhong Huang, et al.
Future Microbiology|February 24, 2025
Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infectionFlorian Wagenlehner, Caroline R Perry, Thomas M Hooton, et al.
Trials|February 20, 2025
Opportunities and challenges to delivering a trial for depressive symptoms in primary care during the COVID-19 pandemic: insights from the Alpha-Stim-D randomised controlled trialShireen Patel, Priya Patel, Clement Boutry, et al.
The Lancet. Psychiatry|February 1, 2023
Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trialRichard Morriss, Shireen Patel, Clement Boutry, et al.
Pageof 3